Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
OTC: SFOSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yi Liu
- Employees
- 40,557
- Headquarters
- Shanghai, China
- IPO year
- 2014
- Market cap
- $5.3B
- Website
- https://www.fosunpharma.com
Loading SFOSF…
Loading profile data…Frequently asked questions about SFOSF
What does Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) do?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations ar...
Where does SFOSF trade?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) trades on the Other OTC.
What sector is SFOSF in?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.?
Yi Liu is the chief executive officer of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF).
Where is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. headquartered?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is headquartered in China.
Does SFOSF pay a dividend?
Yes — Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) paid a trailing twelve-month dividend of USD 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SFOSF go public?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) completed its initial public offering in 2014.